Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Xiaowen ^a,b   Cai, Hong ^a,b   Sheng, Weiqi ^a,b   Wang, Yanong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CARCINOMATOUS PERITONITIS; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC PERITONEAL CARCINOMATOSIS; OUTCOME ASSESSMENT; PROGNOSIS; REVIEW; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; ARTICLE; CARCINOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PERITONEUM; PERITONEUM TUMOR; STOMACH TUMOR;

CARCINOMA; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84861212909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037284     Document Type: Review

References (14)

1. Shibata A, Parsonnet J, Stomach cancer (2006) Cancer epidemiology and prevention, 3rd edn New York Oxford University Press pp. 707-720.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Yamada E, Miyaishi S, Nakazato H, (1980) The surgical treatment of cancer of the stomach. Int Surg 65: 387-399.
4. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, et al. (2000) Peritoneal carcinomatosis from nongynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88: 358-363.
5. Saito H, Tsujitani S, Kondo A, Ikequchi M, Maeta M, et al. (1999) Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery 125: 195-201.
6. Oh CA, Bae JM, Oh SJ, Choi MG, Noh JH, et al. (2012) Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology. J Surg Oncol 105: 393-399.
7. Sarela AI, Miner TJ, Karpeh MS, Coit DF, Jaques DP, et al. (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243: 189-195.
8. Kostić Z, Cuk V, Bokun R, Ignjatović D, Usaj-Knezević S, et al. (2006) Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma. Vojnosanit Pregl 63: 349-56.
9. Yonemura Y, (1998) Mechanisms of the formation of peritoneal dissemination. In: Yonemura Y, editors. Peritoneal dissemination Kanazawa Maeda Shoten pp. 1-129.
10. Sakata Y, Ohtsu A, Horikoshi N, Suqimachi K, Mitachi Y, et al. (1998) Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M ostat potassium) in advanced gastric cancer patients. Eur J Cancer 34: 1715-1720.
11. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, et al. (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221.
12. Saito H, Kihara K, Kuroda H, Matsunaga T, Tatebe S, et al. (2011) Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis. J Surg Oncol 104: 534-537.
13. Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yaqi Y, et al. (2009) Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 250: 242-246.
14. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, et al. (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18: 1575-1581.